1. Home
  2. TFIN vs PGEN Comparison

TFIN vs PGEN Comparison

Compare TFIN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Triumph Financial Inc.

TFIN

Triumph Financial Inc.

HOLD

Current Price

$75.36

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.07

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFIN
PGEN
Founded
1981
1998
Country
United States
United States
Employees
1450
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
TFIN
PGEN
Price
$75.36
$7.07
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$66.20
$8.33
AVG Volume (30 Days)
279.3K
4.9M
Earning Date
04-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
N/A
$230,981,000.00
Revenue This Year
$7.27
$1,115.92
Revenue Next Year
$11.31
$81.04
P/E Ratio
$66.31
$241.00
Revenue Growth
N/A
N/A
52 Week Low
$46.43
$1.72
52 Week High
$83.52
$7.26

Technical Indicators

Market Signals
Indicator
TFIN
PGEN
Relative Strength Index (RSI) 46.61 72.86
Support Level $73.95 $3.37
Resistance Level $78.60 N/A
Average True Range (ATR) 3.06 0.41
MACD -0.40 0.14
Stochastic Oscillator 18.40 87.41

Price Performance

Historical Comparison
TFIN
PGEN

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company based in the United States. Along with its subsidiaries, the company operates in four reportable segments: Banking, Factoring, Payments, and Intelligence. The Banking segment, which generates maximum revenue, includes the operations of TBK Bank, offering traditional banking services. The Factoring segment provides working capital solutions to the trucking industry through the purchase of invoices generated by carriers at a discount. The Payments segment provides payment, audit, and other banking services for the over-the-road trucking industry, and the Intelligence segment operates to turn the over-the-road trucking data collected through the services offered into actionable insights for its customers.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: